CNBC Squawk July 4, 2024
On pharma. Eli lilly with earnings. Novo nordisk, the drug cutting risk of heart attack and stroke by 20 well talk to mr. Irgin and echo star ceo a day after s p and nasdaq broke the fourday losing streak, stocks back in the red financials in focus among laggards after moodys talking about Interest Rate and asset liability risk. Whats incredible is we just went through the quarters. With the exception of, honestly, key, the quarters were good. A lot of them had inflows. People thought there would be outflows david, when you see these kinds of downgrades, dont you see yes, yes, yes. Good, good,...
Source: archive.org
